Glucotim La Eye Drops 5Ml

GLUCOTIM LA EYE DROPS 5ML interacts with the following medicines:

• Oral beta-blockers such as propranolol and metoprolol: The concomitant use may cause additive cardiovascular effects, including bradycardia and hypotension.
• Calcium channel blockers such as verapamil, diltiazem, and nifedipine: The concomitant use may increase the risk of heart conduction abnormalities.
• Antihypertensives/Cardiac Glycosides such as digoxin: Concomitant use with antihypertensives or cardiac glycosides such as digoxin may potentiate hypotension or bradycardia due to additive cardiovascular effects.
• Antihypertensive agents such as clonidine or reserpine: The concomitant use may enhance blood pressure-lowering effects and increase the risk of marked hypotension.
• Class IA antiarrhythmic agents such as quinidine: The concomitant use may increase systemic beta-blockade and potentiate cardiovascular adverse effects.
• Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine and paroxetine: Concomitant use may increase timolol plasma concentrations through CYP2D6 inhibition, enhancing beta-blocker effects.
• Adrenergic agonists such as adrenaline: The concomitant use may modify pupillary response and alter cardiovascular reactions.
• Anaesthetic agents: The concomitant use may increase the risk of hypotension and cardiac depression during surgical procedures.

GLUCOTIM LA EYE DROPS 5ML interacts with the following diseases:

• Bronchial Asthma: Patients with a history of bronchial asthma may experience an exacerbation of their condition when using GLUCOTIM LA EYE DROPS 5ML.
• Chronic Obstructive Pulmonary Disease (COPD): Those with severe COPD should avoid using this medication, as it may worsen their condition.
• Cardiac Disorders: Patients with sinus bradycardia, atrioventricular block, cardiac failure, or cardiogenic shock should be cautious, as the timolol component of GLUCOTIM LA EYE DROPS 5ML can affect heart function.
• Raynaud's Phenomenon: GLUCOTIM LA EYE DROPS 5ML should be used with caution in patients with Raynaud's phenomenon, as it may worsen peripheral vasospasm and reduce blood flow to the extremities.
• Diabetes: Timolol can mask the symptoms of hypoglycaemia, such as rapid heartbeat, making it harder to recognise low blood sugar levels. Diabetic patients should monitor their blood glucose levels closely.
• Myasthenia Gravis: Timolol may exacerbate muscle weakness in patients with myasthenia gravis, leading to increased symptoms. Close monitoring and consultation with a healthcare provider are essential.

The daily dose of GLUCOTIM LA EYE DROPS 5ML should be used as suggested by your doctor. Always adhere to the prescribed dosage, and never modify it without your doctor's advice.

If you accidentally use more GLUCOTIM LA EYE DROPS 5ML than recommended, don't panic. Rinse your eyes with clean, room-temperature water. If you notice persistent or worsening symptoms, inform your doctor. Accidental ingestion or excessive systemic absorption may cause symptoms such as slow heart rate, low blood pressure, breathing difficulty, dizziness, or fainting. Seek immediate medical attention if these occur.

Instil the missed dose of GLUCOTIM LA EYE DROPS 5ML as soon as remembered, unless it is nearly time for the next dose. Do not apply a double dose.